日本黄色小说视频,日韩在线一区二区三区免费视频,亚洲电影在线,精品欧美日韩一区二区三区,久久香蕉国产线看观看亚洲卡,美女浴室,美女脱衣诱惑

資訊|論壇|病例

搜索

首頁 醫(yī)學論壇 專業(yè)文章 醫(yī)學進展 簽約作者 病例中心 快問診所 愛醫(yī)培訓(xùn) 醫(yī)學考試 在線題庫 醫(yī)學會議

您所在的位置:首頁 > 專業(yè)交流 > BMC Endocr Disord:強化降糖治療發(fā)生低血糖的因素預(yù)測

BMC Endocr Disord:強化降糖治療發(fā)生低血糖的因素預(yù)測

2013-01-10 09:30 閱讀:2273 來源:醫(yī)學論壇網(wǎng) 責任編輯:鄺兆進
[導(dǎo)讀] 德國研究者進行的一項前瞻性研究(BMC Endocr Disord. 2012 Oct 17;12(1):23)表明,低血糖是接受強化降糖治療的2型糖尿病門診患者的常見并發(fā)癥。既往發(fā)生過低血糖、微血管疾?。ㄈ缫暰W(wǎng)膜病變)和接受胰島素治療的患者,尤其需要注意預(yù)防低血糖發(fā)生。服用噻唑

  德國研究者進行的一項前瞻性研究(BMC Endocr Disord. 2012 Oct 17;12(1):23)表明,低血糖是接受強化降糖治療的2型糖尿病門診患者的常見并發(fā)癥。既往發(fā)生過低血糖、微血管疾?。ㄈ缫暰W(wǎng)膜病變)和接受胰島素治療的患者,尤其需要注意預(yù)防低血糖發(fā)生。服用噻唑烷二酮類藥物、DPP-4抑制劑與GLP-1類似物的患者發(fā)生低血糖的風險較低。

強化降糖治療

  DiaRegis是一項前瞻性注冊研究,入選3810例接受強化降糖治療的2型糖尿病患者。全部3347例取得數(shù)據(jù)的患者中,12個月隨訪期內(nèi)共出現(xiàn)473(14.1%)例低血糖。發(fā)生低血糖的患者糖尿病病程較長、糖化血紅蛋白(HbA1c)水平更高、既往有吸煙史的比例更高。此外,發(fā)生低血糖的患者在基線時合并其他疾病如冠脈疾病、外周血管病、心衰、截肢、周圍神經(jīng)病變、糖尿病視網(wǎng)膜病變與抑郁的比例更高。

  Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry

  Background

  Hypoglycaemia is a serious adverse effect of antidiabetic drug therapy. We aimed to determine incidence rates of hypoglycaemia in type-2 diabetic patients and identify predictors of hypoglycaemia when treatment is intensified.

  Methods

  DiaRegis is a prospective German registry that follows 3810 patients with type-2 diabetes referred for treatment intensification because of insufficient glycaemic control on one or two oral antidiabetic drugs.

  Results

  Out of a total of 3347 patients with data available for the present analysis 473 (14.1%) presented any severity hypoglycaemia over a follow-up of 12 months. 0.4% were hospitalized (mean of 1.3±0.6 episodes), 0.1% needed medical assistance (1.0±0.0), 0.8% needed any help (1.1±0.5) and 10.1% no help (3.4±3.7), and 8.0% had no specific symptoms (3.6±3.5). Patients with incident hypoglycaemia had longer diabetes duration, higher HbA1c and a more frequent smoking history; more had co-morbid disease conditions such as coronary artery disease, pe**heral arterial disease, amputation, heart failure, pe**heral neuropathy, diabetic retinopathy and clinically relevant depression at baseline. Multivariable adjusted positive predictors of incident hypoglycaemia over the follow-up were prior anamnestic hypoglycaemia, retinopathy, depression, insulin use and blood glucose self-measurement, but not sulfonylurea use as previously reported for anamnestic or recalled hypogylcaemia. On the contrary, glitazones, DPP-4 inhibitors and GLP-1 analogues were associated with a reduced risk of hypoglycaemia.

  Conclusions

  Hypoglycaemia is a frequent adverse effect in ambulatory patients when antidiabetic treatment is intensified. Particular attention is warranted in patients with prior episodes of hypoglycaemia, microvascular disease such as retinopathy and in patients receiving insulin. On the other hand glitazones, DPP-4 inhibitors and GLP-1 analogues are associated with a reduced risk.


分享到:
  版權(quán)聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們

  聯(lián)系zlzs@120.net,我們將立即進行刪除處理

意見反饋 關(guān)于我們 隱私保護 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved